Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-021415
Filing Date
2018-08-03
Accepted
2018-08-03 17:43:59
Documents
1
Period of Report
2018-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7268
  Complete submission text file 0000899243-18-021415.txt   8599
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CRISPR THERAPEUTICS AG 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
Ho Tony W (Reporting) CIK: 0001713637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 18993008